TheraTarget will usher in the clinical application of a novel, safe, biodegradable, first in class, polymeric HPMA drug delivery platform adorned with a variety immuno-activating and immuno-modulating agents designed to optimize cancer immunotherapy resulting in increased efficacy while significantly reducing adverse effects.
Member count: 1-10
Founded date: 2008
Investors 1
| Date | Name | Website |
| - | Technology... | pivotcente... |